Jon J. van Rood

8.6k total citations · 1 hit paper
114 papers, 6.5k citations indexed

About

Jon J. van Rood is a scholar working on Immunology, Hematology and Transplantation. According to data from OpenAlex, Jon J. van Rood has authored 114 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 35 papers in Hematology and 23 papers in Transplantation. Recurrent topics in Jon J. van Rood's work include T-cell and B-cell Immunology (52 papers), Immune Cell Function and Interaction (32 papers) and Hematopoietic Stem Cell Transplantation (30 papers). Jon J. van Rood is often cited by papers focused on T-cell and B-cell Immunology (52 papers), Immune Cell Function and Interaction (32 papers) and Hematopoietic Stem Cell Transplantation (30 papers). Jon J. van Rood collaborates with scholars based in Netherlands, United States and Germany. Jon J. van Rood's co-authors include Frans H.J. Claas, Fritz H. Bach, Andromachi Scaradavou, Cladd E. Stevens, Els Goulmy, Robert Peter Gale, Mary M. Horowitz, John E. Wagner, Juliet N. Barker and Hillard M. Lazarus and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jon J. van Rood

113 papers receiving 6.2k citations

Hit Papers

Outcomes after Transplantation of Cord Blood or Bone Marr... 2004 2026 2011 2018 2004 250 500 750

Peers

Jon J. van Rood
S Slavin Israel
J. J. van Rood Netherlands
George E. Sale United States
B Chapuis Switzerland
J. Alejandro Madrigal United Kingdom
Robertson Parkman United States
S Slavin Israel
Jon J. van Rood
Citations per year, relative to Jon J. van Rood Jon J. van Rood (= 1×) peers S Slavin

Countries citing papers authored by Jon J. van Rood

Since Specialization
Citations

This map shows the geographic impact of Jon J. van Rood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon J. van Rood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon J. van Rood more than expected).

Fields of papers citing papers by Jon J. van Rood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon J. van Rood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon J. van Rood. The network helps show where Jon J. van Rood may publish in the future.

Co-authorship network of co-authors of Jon J. van Rood

This figure shows the co-authorship network connecting the top 25 collaborators of Jon J. van Rood. A scholar is included among the top collaborators of Jon J. van Rood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon J. van Rood. Jon J. van Rood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schonewille, Henk, Jon J. van Rood, Esther P. Verduin, et al.. (2018). Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness. Haematologica. 104(2). 263–268. 1 indexed citations
2.
Pingel, Julia, Tao Wang, Arnon Nagler, et al.. (2018). The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR. Bone Marrow Transplantation. 54(6). 849–857. 3 indexed citations
3.
Kooy–Winkelaar, Yvonne, George M. C. Janssen, Allan Thompson, et al.. (2017). CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proceedings of the National Academy of Sciences. 114(6). E980–E989. 41 indexed citations
4.
Heidt, Sebastiaan, Geert W. Haasnoot, Jon J. van Rood, Marian D. Witvliet, & Frans H.J. Claas. (2017). Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients. Kidney International. 93(2). 491–500. 47 indexed citations
5.
Eikmans, Michael, Astrid G. S. van Halteren, Koen van Besien, et al.. (2014). Naturally acquired microchimerism. PubMed. 5(2). 24–39. 35 indexed citations
6.
Rood, Jon J. van, Cladd E. Stevens, Jacqueline M. Smits, et al.. (2009). Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proceedings of the National Academy of Sciences. 106(47). 19952–19957. 99 indexed citations
7.
Laughlin, Mary J., Mary Eapen, Pablo Rubinstein, et al.. (2005). Outcomes After Transplantation of Cord Blood or Bone Marrow From Unrelated Donors in Adults With Leukemia. Obstetrical & Gynecological Survey. 60(5). 295–296. 131 indexed citations
8.
Seebach, Jörg D., Georg Stüssi, Jakob Passweg, et al.. (2005). ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited. Biology of Blood and Marrow Transplantation. 11(12). 1006–1013. 96 indexed citations
9.
Heemskerk, Martin B.A., Dave L. Roelen, Jon J. van Rood, et al.. (2005). Allogeneic MHC Class I Molecules With Numerous Sequence Differences Do Not Elicit a CTL Response. Human Immunology. 66(9). 969–976. 40 indexed citations
10.
Rood, Jon J. van & Frans H.J. Claas. (2000). Noninherited maternal HLA antigens: a proposal to elucidate their role in the immune response. Human Immunology. 61(12). 1390–1394. 14 indexed citations
11.
Rood, Jon J. van & Frans H.J. Claas. (2000). Both self and non-inherited maternal HLA antigens influence the immune response. Immunology Today. 21(6). 269–273. 49 indexed citations
12.
Rood, Jon J. van & A. van Leeuwen. (1999). Soluble HLA antigens:. Human Immunology. 60(5). 412–413. 2 indexed citations
13.
Goulmy, Els, R.F. Schipper, Jos Pool, et al.. (1996). Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation. New England Journal of Medicine. 334(5). 281–285. 443 indexed citations
14.
Roelen, Dave L., et al.. (1994). CYTOTOXIC T LYMPHOCYTES AGAINST HLA-B ANTIGENS ARE LESS NAIVE THAN CYTOTOXIC T LYMPHOCYTES AGAINST HLA-A ANTIGENS. Transplantation. 57(3). 446–450. 21 indexed citations
15.
Köster, Helene, Jon J. van Rood, & A. Termijtelen. (1992). HLA‐DR peptide‐induced alloreactive T cell lines reveal an HLA‐DR sequence that can be both “dominant” and “cryptic”: evidence for allele‐specific processing. European Journal of Immunology. 22(6). 1531–1539. 14 indexed citations
16.
Rood, Jon J. van, et al.. (1991). Minor histocompatibility antigens, defined by graft‐vs.‐host disease‐derived cytotoxic T lymphocytes, show variable expression on human skin cells. European Journal of Immunology. 21(11). 2839–2844. 23 indexed citations
17.
Planque, Mariet M. de, Hanneke C. Kluin‐Nelemans, J. Han van Krieken, et al.. (1988). Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. British Journal of Haematology. 70(1). 55–62. 109 indexed citations
19.
Claas, Frans H.J., et al.. (1983). Platelet and granulocyte specific allo‐antigens in chimpanzees. Tissue Antigens. 22(3). 219–226. 4 indexed citations
20.
Balner, H. & Jon J. van Rood. (1972). Transplantation genetics of primates. Grune & Stratton eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026